Shots: The US FDA approved 10 NDAs and 3 BLA in August 2023, leading to treatments...
Shots: PharmaShots' designation report provides a concise overview...
Shots: To keep our readers acquainted with several disease conditions, ongoing trials,...
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and...
Shots: PharmaShots’ second dose of the Know Your Investor series focuses on...
Shots: The EMA approved 9 New Chemical Entity (NCE) and 5 Biologic Drugs in July 2...